These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 11721959)
1. RUNX1/AML1: a central player in hematopoiesis. Okuda T; Nishimura M; Nakao M; Fujita Y Int J Hematol; 2001 Oct; 74(3):252-7. PubMed ID: 11721959 [TBL] [Abstract][Full Text] [Related]
2. The role of the AML1 transcription factor in leukemogenesis. Lorsbach RB; Downing JR Int J Hematol; 2001 Oct; 74(3):258-65. PubMed ID: 11721960 [TBL] [Abstract][Full Text] [Related]
3. The transcriptionally active form of AML1 is required for hematopoietic rescue of the AML1-deficient embryonic para-aortic splanchnopleural (P-Sp) region. Goyama S; Yamaguchi Y; Imai Y; Kawazu M; Nakagawa M; Asai T; Kumano K; Mitani K; Ogawa S; Chiba S; Kurokawa M; Hirai H Blood; 2004 Dec; 104(12):3558-64. PubMed ID: 15271791 [TBL] [Abstract][Full Text] [Related]
4. The AML1 transcription factor functions to develop and maintain hematogenic precursor cells in the embryonic aorta-gonad-mesonephros region. Mukouyama Y; Chiba N; Hara T; Okada H; Ito Y; Kanamaru R; Miyajima A; Satake M; Watanabe T Dev Biol; 2000 Apr; 220(1):27-36. PubMed ID: 10720428 [TBL] [Abstract][Full Text] [Related]
5. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis. Kalev-Zylinska ML; Horsfield JA; Flores MV; Postlethwait JH; Vitas MR; Baas AM; Crosier PS; Crosier KE Development; 2002 Apr; 129(8):2015-30. PubMed ID: 11934867 [TBL] [Abstract][Full Text] [Related]
6. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias. Lo Coco F; Pisegna S; Diverio D Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595 [TBL] [Abstract][Full Text] [Related]
7. Runx1/AML-1 ranks as a master regulator of adult hematopoiesis. Ichikawa M; Asai T; Chiba S; Kurokawa M; Ogawa S Cell Cycle; 2004 Jun; 3(6):722-4. PubMed ID: 15213471 [TBL] [Abstract][Full Text] [Related]
8. Core-binding factor: a central player in hematopoiesis and leukemia. Speck NA; Stacy T; Wang Q; North T; Gu TL; Miller J; Binder M; Marín-Padilla M Cancer Res; 1999 Apr; 59(7 Suppl):1789s-1793s. PubMed ID: 10197598 [TBL] [Abstract][Full Text] [Related]
9. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Okuda T; van Deursen J; Hiebert SW; Grosveld G; Downing JR Cell; 1996 Jan; 84(2):321-30. PubMed ID: 8565077 [TBL] [Abstract][Full Text] [Related]
10. Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesis. Peterson LF; Lo MC; Okumura AJ; Zhang DE Blood Cells Mol Dis; 2007; 39(3):321-8. PubMed ID: 17692541 [TBL] [Abstract][Full Text] [Related]
11. Role of AML1/Runx1 in the pathogenesis of hematological malignancies. Kurokawa M; Hirai H Cancer Sci; 2003 Oct; 94(10):841-6. PubMed ID: 14556655 [TBL] [Abstract][Full Text] [Related]
12. Identification of an alternatively spliced form of the mouse AML1/RUNX1 gene transcript AML1c and its expression in early hematopoietic development. Fujita Y; Nishimura M; Taniwaki M; Abe T; Okuda T Biochem Biophys Res Commun; 2001 Mar; 281(5):1248-55. PubMed ID: 11243869 [TBL] [Abstract][Full Text] [Related]
13. The homeodomain protein Meis1 is essential for definitive hematopoiesis and vascular patterning in the mouse embryo. Azcoitia V; Aracil M; Martínez-A C; Torres M Dev Biol; 2005 Apr; 280(2):307-20. PubMed ID: 15882575 [TBL] [Abstract][Full Text] [Related]
14. AML1 interconnected pathways of leukemogenesis. Michaud J; Scott HS; Escher R Cancer Invest; 2003; 21(1):105-36. PubMed ID: 12643014 [TBL] [Abstract][Full Text] [Related]
15. Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro. Lacaud G; Gore L; Kennedy M; Kouskoff V; Kingsley P; Hogan C; Carlsson L; Speck N; Palis J; Keller G Blood; 2002 Jul; 100(2):458-66. PubMed ID: 12091336 [TBL] [Abstract][Full Text] [Related]
16. The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications. Asou N Crit Rev Oncol Hematol; 2003 Feb; 45(2):129-50. PubMed ID: 12604126 [TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of runxa and runxb, zebrafish members of the runt family of transcriptional regulators. Burns CE; DeBlasio T; Zhou Y; Zhang J; Zon L; Nimer SD Exp Hematol; 2002 Dec; 30(12):1381-9. PubMed ID: 12482499 [TBL] [Abstract][Full Text] [Related]
18. An acute myeloid leukemia gene, AML1, regulates transcriptional activation and hemopoietic myeloid cell differentiation antagonistically by two alternative spliced forms. Tanaka T; Tanaka K; Ogawa S; Kurokawa M; Mitani K; Yazaki Y; Shibata Y; Hirai H Leukemia; 1997 Apr; 11 Suppl 3():299-302. PubMed ID: 9209372 [TBL] [Abstract][Full Text] [Related]
19. Biological characteristics of the leukemia-associated transcriptional factor AML1 disclosed by hematopoietic rescue of AML1-deficient embryonic stem cells by using a knock-in strategy. Okuda T; Takeda K; Fujita Y; Nishimura M; Yagyu S; Yoshida M; Akira S; Downing JR; Abe T Mol Cell Biol; 2000 Jan; 20(1):319-28. PubMed ID: 10594034 [TBL] [Abstract][Full Text] [Related]
20. Core binding factor and its role in normal hematopoietic development. Speck NA Curr Opin Hematol; 2001 Jul; 8(4):192-6. PubMed ID: 11561154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]